Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea

NCT05101122 is registered in ClinicalTrials.gov with Apnimed as lead sponsor.

NCT NCT05101122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05101122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Lead sponsor
Apnimed
Phase
Phase 1/2
Overall status
Completed
Start date
October 19, 2021
Completion date
April 18, 2022
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea